Argenx
ARGX
#542
Rank
NZ$62.01 B
Marketcap
$1,003
Share price
0.99%
Change (1 day)
58.80%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2023 (TTM): -$6.80

According to Argenx 's latest financial reports the company's current EPS (TTM) is -$6.95. In 2022 the company made an earnings per share (EPS) of -$21.92.

EPS history for Argenx from 2022 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$6.80-68.96%
2022-$21.92